GLP-1 Titration Guide

What titration means

Titration is the process of starting a medication at a low dose and increasing it in steps over time, rather than beginning at the full therapeutic dose. GLP-1 receptor agonists are always titrated because starting at the target dose causes significant gastrointestinal side effects in most people.

The goal of titration is to find the lowest dose that provides meaningful effect while producing tolerable (or no) side effects. For some people, that target dose is the lowest available; for others it is the maximum. The relationship between dose and effect is individual — there is no single “right” answer.

Titration schedules on the approved brand-name drugs are defined in prescribing information. Your prescriber may follow those schedules, deviate from them with clinical justification, or adjust based on how you respond. The schedules described here are illustrative; always follow what your prescriber tells you.

Standard vs slow titration: what members report

Standard schedule

The standard schedule for weekly GLP-1 injections typically steps the dose up every four weeks. For semaglutide, this means four weeks at 0.25 mg, four weeks at 0.5 mg, and continuing up through 1 mg and 2 mg as tolerated. Tirzepatide follows a similar cadence with different dose levels.

Slow titration

Many members — especially those who experience significant nausea — report staying at each dose level for 8–12 weeks before stepping up, rather than the standard four weeks. This is sometimes called a “slow taper up” or extended titration. The trade-off is that reaching a higher dose takes longer, but side effects are often more manageable along the way.

Slow titration is not a workaround or a medical recommendation — it is a documented approach that some prescribers use when standard titration is not well-tolerated. If you are struggling with side effects, the conversation to have is with your prescriber, not a dose change on your own.

When to consider stepping up a dose

The standard answer is: when your prescriber says so, after the recommended time at the current dose and without significant remaining side effects. Signs that members describe as prompting a dose-step discussion with their prescriber:

• Reaching the end of the standard four-week (or extended) period at the current dose with side effects that have settled to mild or none
• Appetite suppression or glycemic effect that was noticeable earlier in the dose period has diminished by the end of the period
• Weight loss has plateaued over multiple weeks at the same dose, after ruling out other factors

What is NOT a reason to step up on your own: impatience or reading that a higher dose produces faster results. Higher doses carry higher side effect burdens and, in some cases, risks that a prescriber needs to weigh. This is a conversation to have with your clinical team.

Weight-loss stalls: what the community has found

A stall — a period of weeks where weight is not moving — is one of the most common topics in this forum. Most members find that stalls are temporary and often do not reflect a medication problem. Before assuming the dose needs to change, the community typically checks:

• Calorie intake drift: appetite suppression can fade at a stable dose. Members often find that tracking food for a week reveals that intake has gradually crept back up without notice.
• Protein intake: inadequate protein on a caloric deficit accelerates muscle loss, which slows the metabolic rate and can stall fat loss. See the protein and muscle preservation guide.
• Sleep and stress: both significantly affect weight loss independent of medication. High cortisol from poor sleep or chronic stress can suppress fat loss even in a caloric deficit.
• Water retention: hormonal fluctuations, high sodium, and changes in exercise can temporarily increase water weight, masking fat loss on the scale.
• Duration: a true plateau is generally defined as 4–6 weeks with no movement, not one or two weeks. Short flat periods are normal.

If a genuine plateau persists after checking these factors, that is the time to discuss a dose increase with your prescriber. Do not increase the dose before having that conversation.

Working with your prescriber on titration

Titration decisions belong to you and your prescriber together. Some things that make those conversations more productive, based on what members report:

• Track your side effects by dose: note when they started, how severe they were, and when they resolved. This gives your prescriber something concrete to work with rather than “I felt sick for a while.”
• Track your weight weekly, same conditions: morning, same scale, without clothes. Consistent measurements make a stall easier to confirm or rule out.
• Bring your current medication log: when you injected, what dose, and any side effects that week. A short written record is more useful than memory.
• Ask specifically about the next dose level: what to expect side-effect-wise, what the plan is if side effects are severe, and whether slow titration is appropriate for your situation.

A prescriber who is engaged with your progress is your most important resource. If your prescriber is not asking about side effects or discussing titration plans, it is reasonable to raise it yourself.